Literature DB >> 27329810

ALKBH8 promotes bladder cancer growth and progression through regulating the expression of survivin.

Ikumi Ohshio1, Ryoji Kawakami1, Yohei Tsukada1, Kazuhiro Nakajima1, Kaori Kitae1, Tomoki Shimanoe1, Yasuka Saigo1, Hiroaki Hase1, Yuko Ueda1, Kentaro Jingushi2, Kazutake Tsujikawa1.   

Abstract

Human AlkB homolog 8 (ALKBH8) is highly expressed in high-grade, superficially and deeply invasive bladder cancer. Moreover, ALKBH8 knockdown induces apoptosis in bladder cancer cells. However, the underlying anti-apoptotic mechanism of ALKBH8 in bladder cancer cells has thus far remained unclear. Moreover, there is no direct evidence that highly expressed ALKBH8 is involved in tumor progression in vivo. We here show that ALKBH8 knockdown induced apoptosis via downregulating the protein expression of survivin, an anti-apoptotic factor also exhibiting increased levels in bladder cancer. We also clarify that ALKBH8 transgenic mice showed an accelerated rate of bladder tumor mass and invasiveness in an N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced bladder cancer model. These findings suggest that the high expression of ALKBH8 is critical for the growth and progression of bladder cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALKBH8; Anti-apoptotic factor; Bladder cancer; Tumor progression

Mesh:

Substances:

Year:  2016        PMID: 27329810     DOI: 10.1016/j.bbrc.2016.06.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Multi-substrate selectivity based on key loops and non-homologous domains: new insight into ALKBH family.

Authors:  Baofang Xu; Dongyang Liu; Zerong Wang; Ruixia Tian; Yongchun Zuo
Journal:  Cell Mol Life Sci       Date:  2020-07-08       Impact factor: 9.261

2.  RNA modifications and cancer.

Authors:  Phensinee Haruehanroengra; Ya Ying Zheng; Yubin Zhou; Yun Huang; Jia Sheng
Journal:  RNA Biol       Date:  2020-02-07       Impact factor: 4.652

Review 3.  The plasticity of mRNA translation during cancer progression and therapy resistance.

Authors:  Lucilla Fabbri; Alina Chakraborty; Caroline Robert; Stéphan Vagner
Journal:  Nat Rev Cancer       Date:  2021-08-02       Impact factor: 60.716

4.  Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.

Authors:  Dingxiang Dong; Weifan Jiang; Jun Lei; Leifeng Chen; Xiuxia Liu; Jin Ge; Ben Che; Xiaoqing Xi; Jianghua Shao
Journal:  Oncotarget       Date:  2016-12-06

Review 5.  tRNA-Derived Small RNAs: Biogenesis, Modification, Function and Potential Impact on Human Disease Development.

Authors:  Vera Oberbauer; Matthias R Schaefer
Journal:  Genes (Basel)       Date:  2018-12-05       Impact factor: 4.096

6.  ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer.

Authors:  Kentaro Jingushi; Masaya Aoki; Kazuhiro Ueda; Takahiro Kogaki; Masaya Tanimoto; Yuya Monoe; Masayuki Ando; Takuya Matsumoto; Kentaro Minami; Yuko Ueda; Kaori Kitae; Hiroaki Hase; Toshiyuki Nagata; Aya Harada-Takeda; Masatatsu Yamamoto; Kohichi Kawahara; Kazuhiro Tabata; Tatsuhiko Furukawa; Masami Sato; Kazutake Tsujikawa
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

7.  Single-cell spatial transcriptomic analysis reveals common and divergent features of developing postnatal granule cerebellar cells and medulloblastoma.

Authors:  Wenqin Luo; Guan Ning Lin; Weichen Song; Yu Zhang; Huadong Lai; Man Zhang; Juju Miao; Xiaomu Cheng; Yongjie Wang; Wang Li; Wenxiang Wei; Wei-Qiang Gao; Ru Yang; Jia Wang
Journal:  BMC Biol       Date:  2021-07-01       Impact factor: 7.431

Review 8.  Disruption of the RNA modifications that target the ribosome translation machinery in human cancer.

Authors:  Maxime Janin; Laia Coll-SanMartin; Manel Esteller
Journal:  Mol Cancer       Date:  2020-04-02       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.